Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy

Hayden, Melvin R.; Tyagi, Suresh C.
January 2002
Cardiovascular Diabetology;2002, Vol. 1, p3
Academic Journal
Metabolic syndrome, insulin resistance, prediabetes, and overt type 2 diabetes mellitus are associated with an accelerated atherosclerosis (atheroscleropathy). This quartet is also associated with multiple metabolic toxicities resulting in the production of reactive oxygen species. The redox stress associated with these reactive oxygen species contribute to the development, progression, and the final fate of the arterial vessel wall in prediabetic and diabetic atheroscleropathy. The prevention of morbidity and mortality of these intersecting metabolic diseases can be approached through comprehensive global risk reduction.


Related Articles

  • Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis. Kaneto, Hideaki; Katakami, Naoto; Matsuhisa, Munehide; Matsuoka, Taka-aki // Mediators of Inflammation;2010, Vol. 2010, p1 

    Type 2 diabetes is the most prevalent and serious metabolic disease all over the world, and its hallmarks are pancreatic β-cell dysfunction and insulin resistance. Under diabetic conditions, chronic hyperglycemia and subsequent augmentation of reactive oxygen species (ROS) deteriorate...

  • The Role of Vaspin in the Development of Metabolic and Glucose Tolerance Disorders and Atherosclerosis. Dimova, Rumyana; Tankova, Tsvetalina // BioMed Research International;4/6/2015, Vol. 2015, p1 

    In recent years, most research efforts have been focused on studying insulin-sensitizing adipokines. One of the most recently discovered adipokines is vaspin, a visceral adipose tissue-derived serine protease inhibitor. Vaspin levels have been found significantly increased in mice with obesity...

  • The CAPN10 Gene Is Associated with Insulin Resistance Phenotypes in the Spanish Population. Sáez, María E.; González-Sánchez, José L.; Ramírez-Lorca, Reposo; Martínez-Larrad, María T.; Zabena, Carina; González, Alejandro; Morón, Francisco J.; Ruiz, Agustín; Serrano-Ríos, Manuel // PLoS ONE;2008, Vol. 3 Issue 8, p1 

    Cardiovascular disease is the leading cause of morbidity and mortality in the industrialized world. Familial aggregation of cardiovascular risk factors is a frequent finding, but genetic factors affecting its presentation are still poorly understood. The calpain 10 gene (CAPN10) has been...

  • Metabolic Syndrome and Diabetic Atherothrombosis: Implications in Vascular Complications. Meerarani, P.; Badimon, J. J.; Zias, E.; Fuster, V.; Moreno, P. R. // Current Molecular Medicine;Aug2006, Vol. 6 Issue 5, p501 

    Metabolic syndrome is characterized by the clustering of a number of metabolic abnormalities in the presence of underlying insulin resistance with a strong association with diabetes and cardiovascular disease morbidity and mortality. The disorder is defined in different ways, but the...

  • Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleiotropic effects of folate supplementation. Hayden, Melvin R.; Tyagi, Suresh C. // Nutrition Journal;2004, Vol. 3, p4 

    Homocysteine has emerged as a novel independent marker of risk for the development of cardiovascular disease over the past three decades. Additionally, there is a graded mortality risk associated with an elevated fasting plasma total homocysteine (tHcy). Metabolic syndrome (MS) and type 2...

  • The evolving definitions and increasing prevalence of the metabolic syndrome. Desroches, Sophie; Lamarche, Benoît // Applied Physiology, Nutrition & Metabolism;Feb2007, Vol. 32 Issue 1, p23 

    The metabolic syndrome (MetS) represents a cluster of metabolic abnormalities that predisposes an individual to a greater risk of developing coronary heart disease and type 2 diabetes. The condition is widespread among adults from developed nations, and progresses in frequency with age. In...

  • Nutrition Interventions for Prevention of Type 2 Diabetes and the Metabolic Syndrome. Pittas, Anastassios G. // Nutrition in Clinical Care;May-Sep2003, Vol. 6 Issue 2, p79 

    Type 2 diabetes is a chronic disease associated with significant morbidity and mortality that is increasing in prevalence worldwide. Although our current methods for treating type 2 diabetes and its complications have improved, prevention of the disease is preferable, Epidemiologic data suggest...

  • Metabolic syndrome: Call to action. Zoorob, Roger; Smith, Victoria // Cortlandt Forum;Aug2006, Vol. 19 Issue 8, p45 

    The article discusses the association of metabolic syndrome with the increased risk for developing type 2 diabetes and cardiovascular disease. The condition serves as a call for primary-care physicians and patients to begin aggressive treatment regimens that include lifestyle modifications to...

  • Oral Hypoglycemics: A Review of Chemicals Used to Treat Type 2 Diabetes. Zito, S. W.; Shinde, J.; Chen, I-C. S.; Taldone, T.; Barletta, M. // Current Bioactive Compounds;Aug2008, Vol. 4 Issue 2, p68 

    In this review, we focus on the chemicals used in the current treatment of type 2 diabetes and discuss some potentially viable, promising targets in the management of this metabolic syndrome, with a special mention to some naturally occurring bioactive compounds. Non-insulin dependent diabetes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics